ketamine

Ketamine was FDA approved for use in high, anesthetic doses for humans and animals in 1970, and has been studied and used off-label since then for a number of other indications also supported by cognitive behavioral psychotherapy to avoid ketamine misuse, dependence and abuse.

ketamine

Psychedelic Therapy: Does the psychedelic experience matter?

Psychedelic medicines have been studied in the Western medical literature consistently for over 100 years, over 60 of which in the ongoing study and practice of racemic ketamine. Psychedelic experiences are described similarly and often felt as profoundly meaningful.

01 Jun

Terapia Cognitivo-Conductual Psicodélica: sobre la ketamina, el contexto y las competencias en Psicoterapia Asistida

cbt

Psychedelic Cognitive Behavioral Therapy: On Ketamine, Context, and Competencies in "Assisted-Psychotherapy”

There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate therapeutic alliance, including, but not limited to telehealth.

11 May

Costs and barriers to access in psychedelic therapy

at-home ketamine

Increasing Access to Psychedelic-Assisted Psychotherapy : The "proliferation of ketamine clinics" narrative and cost considerations

Psychedelic and psychiatric medicines have been studied for over 100 years as adjuncts to psychotherapy, with over 60 years of ongoing research on the off-label use of racemic ketamine, a generic medicine in various routes of administration with varying levels of support care

23 Apr

ketamine-assisted psychotherapy

Sublingual & Oral Ketamine Research: Efficacy, Dosage, and Treatment for Mental Health

Ongoing review of the literature related to safety and efficacy of ketamine and esketamine by mouth.

23 Apr